The assesment of intraoperative use of mesna in canal wall-up cholesteatoma surgery – preliminary report
Otolaryngologia Polska · 2023
DOI: 10.5604/01.3001.0016.3415 ↗Kurz gefasst
Fachartikel in der Zeitschrift Otolaryngologia Polska, 2023. Verfasst von Marta Pietraszek und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology and Laryngological Oncology, Poznan University of Medical Sciences, Poland. Hauptthemen laut MEDLINE: Cholesteatoma, Middle Ear, Mesna, Otitis Media. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
Introduction
Surgery is still the method of choice in chronic otitis media with cholesteatoma. Except for some specific clinical situations, classic canal wall up technique (CWU), remains a gold standard as a primary treatment in most departments. Unfortunately, the risk of recurrence in such an approach is estimated at 9 to even 70%. This fact prompts researchers to look for ways to reduce those unfavourable statistics. One of the recognized methods supporting the removal of cholesteatoma is the intraoperative use of mesna (sodium 2-mercaptoethanesulfonate). This synthetic sulphur compound disrupts disulfide bridges in polypeptide chains, thanks to which it facilitates matrix preparation.
Aim
To evaluate the effect of intraoperative use of mesna on the treatment outcomes in patients with chronic otitis media with cholesteatoma operated on by means of the canal wall up technique (CWU).
Material and methods: 459 surgical reports of patients with middle ear cholesteatoma were analyzed. In total, 52 adult patients with no history of previous ear surgery operated on by means of the CWU technique by the same experienced otosurgeon with all follow-up data available were included in the study. Twenty-six were operated on with the use of mesna (mesna group) and 26 by means of the classic CWU technique (control / no-mesna group). There were 28 women and 24 men with a mean age of 41 years.
Main Outcome Measure(s): Postoperative hearing results and cholesteatoma recidivism rate.
Results
Overall recidivism rate was 21.15 %. It was higher in the no-mesna (26.9%) than in the mesna group (15.4%) – although the outcomes were better in the mesna group, the difference was not statistically significant (P = 0.49715). Hearing gain was better in the mesna than in the no-mesna group (10 dB vs 7 dB), but the difference was not statistically significant (P = 0.20089).
Conclusions
Our preliminary results show that mesna reduces recidivism rates in patients with cholesteatoma. Further study with the analysis of a larger group of patients is needed to prove it statistically.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology and Laryngological Oncology, Poznan University of Medical Sciences, Poland.
- Department of Otolaryngology and Laryngological Oncology, Medical University of Poznan, Poland.
- Department of Otolaryngology and Laryngological Oncology, Poznan University of Medical Sciences, Poznan, Poland.
Zitieren
APA
Pietraszek, M., Bartochowska, A., Wierzbicka, M., & Gawęcki, W. (2023). The assesment of intraoperative use of mesna in canal wall-up cholesteatoma surgery – preliminary report. Otolaryngologia Polska. https://doi.org/10.5604/01.3001.0016.3415
Vancouver
Pietraszek M, Bartochowska A, Wierzbicka M, Gawęcki W. The assesment of intraoperative use of mesna in canal wall-up cholesteatoma surgery – preliminary report. Otolaryngologia Polska. 2023. doi:10.5604/01.3001.0016.3415
BibTeX
@article{Pietraszek2023,
author = {Pietraszek, Marta and Bartochowska, Anna and Wierzbicka, Małgorzata and Gawęcki, Wojciech},
title = {The assesment of intraoperative use of mesna in canal wall-up cholesteatoma surgery – preliminary report},
journal = {Otolaryngologia Polska},
year = {2023},
doi = {10.5604/01.3001.0016.3415}
}
EUVIMED